EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Evaluation of Sarcopenia in Overweight and Middle-Aged Patients with Diabetes and Its Association with Poor Glycemic Control

Osman Onur Daloğlu, Mehmet Çağrı Ünal, Pınar Üzgeç Güller, Zehra Yağmur Şahin Alak, Metin Güçlü, Sinem Kıyıcı

Endocrinology Research and Practice · 06.07.2026 · 30 (3)

DOI: 10.5152/erp.2026.25873 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology Research and Practice, online erschienen am 06.07.2026. Verfasst von Osman Onur Daloğlu und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Sarcopenia, characterized by reduced muscle mass and strength, commonly affects the elderly. This study aimed to assess sarcopenia in middle-aged, overweight patients with type 2 diabetes (T2D) and examine its relationship with glycemic control.

Methods

This cross-sectional study enrolled 60 patients with T2D, including 30 individuals with poor glycemic control (PGC; glycated hemoglobin (HbA1c) >7%, mean age 54 Å} 5 years, 46.6% women) and 30 with adequate glycemic control (AGC; HbA1c ≤ 7%, mean age 54 Å} 6 years, 50% women). Sarcopenia was evaluated using handgrip strength (HGS), skeletal muscle mass index (SMMI), and the 4-meter walk test, as well as the Sarcopenia Quality of Life (SARQoL) and Pittsburgh Sleep Quality (PSQ) questionnaires.

Results

Sarcopenia was diagnosed in 5 patients (16.6%), all from the PGC group. These patients had significantly lower median HGS (15.4 kg) and SMMI (7.4 kg/m2) compared to those with AGC (29.8 kg and 10.6 kg/m2; P = .021 and .006, respectively). HbA1c negatively correlated with HGS (r = −0.424; P = .001). Multivariate linear regression analysis demonstrated that higher HbA1c levels were independently associated with lower SMMI (β: −0.293; 95% CI: −0.483 to −0.102; P = .003) and lower HGS (β: −2.016; 95% CI: −2.885 to −1.147; P < .001). The SARQoL score was lower in patients with sarcopenia (P = .022), while the PSQ score was similar.

Conclusion

Sarcopenia may develop in non-elderly, overweight patients with poorly controlled diabetes, negatively affecting quality of life. Early screening for sarcopenia should be considered if diabetes is uncontrolled. Cite this article as: Daloglu OO, Unal MC, Guller PU, et al. Evaluation of sarcopenia in overweight and middle-aged patients with diabetes and its association with poor glycemic control. Endocrinol Res Pract. Published online June 1, 2026. doi: 10.5152/erp.2026.25873

Zitieren

APA

Daloğlu, O. O., Ünal, M. Ç., Güller, P. Ü., Alak, Z. Y. Ş., Güçlü, M., & Kıyıcı, S. (2026). Evaluation of Sarcopenia in Overweight and Middle-Aged Patients with Diabetes and Its Association with Poor Glycemic Control. Endocrinology Research and Practice, 30(3). https://doi.org/10.5152/erp.2026.25873

Vancouver

Daloğlu OO, Ünal MÇ, Güller PÜ, Alak ZYŞ, Güçlü M, Kıyıcı S. Evaluation of Sarcopenia in Overweight and Middle-Aged Patients with Diabetes and Its Association with Poor Glycemic Control. Endocrinology Research and Practice. 2026;30(3). doi:10.5152/erp.2026.25873

BibTeX
@article{Dalolu2026,
  author = {Daloğlu, Osman Onur and Ünal, Mehmet Çağrı and Güller, Pınar Üzgeç and Alak, Zehra Yağmur Şahin and Güçlü, Metin and Kıyıcı, Sinem},
  title = {Evaluation of Sarcopenia in Overweight and Middle-Aged Patients with Diabetes and Its Association with Poor Glycemic Control},
  journal = {Endocrinology Research and Practice},
  year = {2026},
  volume = {30},
  number = {3},
  doi = {10.5152/erp.2026.25873}
}
Kostenlos starten →